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ABSTRACT
As a clinical trialist, I had thought that the methods I
employed were far more challenging than those I had
thought were needed for quality improvement.
However, some personal experiences and participation
in the Cliveden conference led me to a new
appreciation of the methodological and conceptual
challenges faced by those trying to improve medical
systems.
Sometimes, one is ambushed by insight. I
had long been ensconced in a cocoon of
what one might call methodological snob-
bery. I had spent my professional life
designing and analysing studies of biomed-
ical interventions, and found their technical,
ethical and inferential challenges endlessly
fascinating. I knew about quality improve-
ment (QI); one of my close medical school
friends had become a leader in paediatric QI,
and a colleague at Johns Hopkins was making
celebrated contributions to the ﬁeld through
his ‘checklist’ approach. But while I viewed
their goals as laudable and their work essen-
tial, I must confess that I viewed the scientiﬁc
challenges they faced, to be polite, as some-
what less daunting than those that regularly
commanded my skills and attention. My
mental model for QI was this; we know what
should be done, and QI is about getting
people to do it. The evaluative part was
seeing if they did it or not. Simple, right?
Well, anyone reading this volume knows
better, and now so do I. I have a new model,
and new insights. My new model is that QI is
about changing complex healthcare systems
to produce collectively better health. These
systems can be as or more complex than the
biological systems affected by the drugs and
devices, and the system changes, like biolog-
ical interventions, can have unexpected
adverse and beneﬁcial effects. My insight was
that far from being beneath me, the skills
and tools necessary for QI included an array
of concepts and tools far broader than I had
been using for evidence-based medicine. The
methods I had spent a lifetime teaching and
using were inadequate for this task. My
methodological snobbery? Simple hubris.
It is hard to say exactly when the light
started to dawn, but I will start with
a personal story. Approximately 8 months
before I was to attend the Cliveden confer-
ence on QI, my mother was diagnosed as
having terminal cancer. She was cared for in
one of New York City’s major academic
hospitals. What I and my family observed
over the course of her stay would not surprise
anyone in QI, nor indeed anyone who has
seen hospital care for a complex illness up
close; an unremitting litany of lapses and
errors that, if not hastening her death,
certainly made her last month of life more
miserable.
I will recount just one of the many episodes
we witnessed. Late in her course, she needed
a new regimen of sedation. It was difﬁcult to
get the changes communicated and imple-
mented through the various care givers, so in
frustration, the head of her palliative care
team took charge and personally made sure
the right cocktail of drugs was ordered and
hung. Many people were involved in the
blizzard of activity provoked by this medica-
tion change. But by morning, it was apparent
that the medications were not working. Why?
Someone had not turned on the intravenous
pump.
As an advocate for the patient in such
situations, one is tempted to use rather blunt
interventions, such as complaining and
yelling loudly at every care giver walking into
the room, or even some passing by. Other
family members did take this tack, and their
complaints were indeed loud enough to be
heard among hospital leadership. These
administrators started a virtual daily parade
of penance to the bedside, albeit marching to
the unchanging bolero beat of continued
lapses.
Hearing me recount this, a colleague
pointed me towards Don Berwick’s classic call
to arms, ‘The Escape Fire,’ which tells an
Correspondence to
Dr Steven Goodman, Johns
Hopkins University, 550 N
Broadway, Suite 1103,
Baltimore, MD 21205, USA;
sgoodman@jhmi.edu
Accepted 17 November 2010
This paper is freely available
online under the BMJ
Journals unlocked scheme,
see http://qualitysafety.bmj.
com/site/about/unlocked.
xhtml
BMJ Qual Saf 2011;20(Suppl 1):i97ei98. doi:10.1136/bmjqs.2010.046623 i97
Rethinking methods of inferenceeerily similar tale of being an eyewitness to a loved one’s
victimisation by a healthcare system seemingly designed
for error, and of the inability of even a Harvard professor
and QI expert at the bedside to change it. This led me to
speak during this period about how ‘the system was
broken,’ with problems complicated enough to defy
simple solutions. But somehow, there was a disconnect
vis-a `-vis QI.
Then, came Cliveden. Although I was not sure exactly
why I was invited, I was attracted by the audacity of
putting ‘epistemology’ into the title of a conference
addressing practical change. And I was, in fact, inter-
ested and informed about the epistemology of clinical
research and felt that one cannot get evaluation strate-
gies right if the epistemology is not understood. But an
epistemology for QI? Oxymoronic, I thought. Doubtful
but intrigued, I crossed the ocean and found myself
surrounded by thoughtful, smart and dedicated scien-
tists, some in disciplines such as mine, and most far
aﬁeld from my own, who had spent careers trying to ﬁx
the broken system I railed against.
Suddenly, I saw what had been before my eyes all
along. QI was not about implementing a change whose
outcome was predictable. Perhaps I had been fooled by
the name, or by analogy to QI efforts in other ﬁelds or
just by sheer inattention. The challenge of QIdboth
intellectual and technicaldwas that even if one knows
what needs to happen at the bedside, one does not
know, at a system level, how to achieve that in a safe,
efﬁcient and sustainable way. And having systems as the
unit of intervention, and perhaps analysis, poses immense
challenges for both implementation and evaluation.
This new awareness also led me to look at clinical
trialsdmy domain of expertisedthrough a different
lens. Clinical trial protocols are often designed to
structure the delivery of care, altering the context in
which an intervention is delivered to minimise the vari-
ability in ancillary care characteristics. This structure is
often derided for limiting the generalisability of clinical
trial ﬁndings, leading to a call for ‘pragmatic’ or ‘prac-
tical’ clinical trials where the effect of an intervention is
assessed ‘au naturel,’ as it will be applied in the
community, with fewer restrictions, which often results in
poorer outcomes. But rather than surrender to real-
world variation, if the clinical trial protocol represents
a system change that improves outcomes, could we use
clinical trials not just to evaluate the intervention, but
also to study which system changes (ie, protocol
elements) are critical for the intervention’s effective-
ness? Could we look to clinical trials not as artiﬁcial care
systems, but instead as model care systems that can
provide clues for what needs to change in our current
models of care delivery? If the clinical trial can study
outcome changes due to a biological intervention, they
can simultaneously be laboratories for examining the
effects of system changes by including arms where such
system modiﬁcations are made.
I will leave it to the other pieces in this volume to ﬂesh
out these issues. But I must confess chagrin at having
dedicated my life to improving medical outcomes by
evaluating interventions without fully appreciating the
complexity of understanding how they are to be imple-
mented within care systems. However, I still have some
life and career in me, and thanks to the Cliveden
conference I look forward to dedicating some fraction
thereof, with new colleagues, to the challenging, fasci-
nating and potentially greatly rewarding ﬁeld of QI.
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